Stocktoria

IRIDEX CORP IRIX

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1996-02-16

IRIDEX CORP statistics & valuation

Market cap$19.7M
P / S0.4×
P / B4.0×
Net margin-8.4%
Return on equity-90.1%
FCF margin-4.3%
Return on capital-16.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-25.40% -30.90% -30.10% -20.30% -17.40% -9.70% -13.20% -18.50% -18.30% -8.40% 2016201720182019202120222022202320242026
Gross margin (%)
45.10% 37.30% 41.00% 41.30% 42.80% 42.40% 44.50% 42.00% 40.10% 36.50% 2016201720182019202120222022202320242026
Operating margin (%)
-5.60% -31.00% -30.20% -20.70% -18.10% -14.00% -13.20% -19.30% -17.10% -4.90% 2016201720182019202120222022202320242026
Return on equity (%)
-29.90% -42.20% -42.80% -38.80% -36.40% -22.40% -43.80% -100.50% -424.90% -90.10% 2016201720182019202120222022202320242026
Shares outstanding
11.3M 11.6M 13.6M 13.8M 13.9M 15.9M 16.0M 16.3M 16.6M 17.3M 2016201720182019202120222022202320242026
Net debt ($)
-$10.4M -$1.4M 2016201720182019202120222022202320242026
Share buybacks ($)
2016201720182019202120222022202320242026
Return on assets (%)
-24.30% -30.90% -30.70% -25.30% -22.60% -10.70% -17.80% -27.80% -30.60% -15.20% 2016201720182019202120222022202320242026
Free cash flow margin (%)
-2.60% -10.00% -24.60% -18.50% -9.20% 14.80% -17.20% -13.20% -15.00% -4.30% 2016201720182019202120222022202320242026
Debt / equity (×)
0.07× 0.48× 2016201720182019202120222022202320242026
EPS ($)
-$1.15 -$1.11 -$1.05 -$0.64 -$0.46 -$0.34 -$0.47 -$0.59 -$0.54 -$0.26 2016201720182019202120222022202320242026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

IRIDEX CORP trades at about 17.4× earnings — below its 10-year norm (10-year range 9.3×–192.6×, median 26.2×).

9.3× 192.6×

Shaded band = 10-year range (9.3×–192.6×); dot = today's 17.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2024FY2023FY2022FY2022FY2021FY2019FY2018FY2017FY2016
Gross margin36.5%40.1%42.0%44.5%42.4%42.8%41.3%41.0%37.3%45.1%
Operating margin-4.9%-17.1%-19.3%-13.2%-14.0%-18.1%-20.7%-30.2%-31.0%-5.6%
Net margin-8.4%-18.3%-18.5%-13.2%-9.7%-17.4%-20.3%-30.1%-30.9%-25.4%
FCF margin-4.3%-15.0%-13.2%-17.2%14.8%-9.2%-18.5%-24.6%-10.0%-2.6%
Return on assets-15.2%-30.6%-27.8%-17.8%-10.7%-22.6%-25.3%-30.7%-30.9%-24.3%
Return on equity-90.1%-424.9%-100.5%-43.8%-22.4%-36.4%-38.8%-42.8%-42.2%-29.9%
Debt / equity—0.48×———0.07×————
Current ratio1.911.422.122.873.342.923.123.773.805.62

Computed from company filings · US · as of 2026-01-03. Facts plus Stocktoria's own computed scores — not investment advice.